top of page

[New paper] Reversion of BRCA1 L1780P mutation confers resistance to PARP and ATM inhibitors in breast cancer

Our new paper has been published in iScience.


In this paper, we conducted genomic analyses using PDX models and cell lines from breast cancer patients with the BRCA1 L1780P mutation and identified that reversion mutations confer resistance to PARP and ATM inhibitors.


Congratulations!


Se-Young Jo. et al. Reversion of pathogenic BRCA1 L1780P mutation confers resistance to PARP and ATM inhibitor in breast cancer. iScience. Volume 27 Issue 8 2024. doi: 10.1016/j.isci.2024.110469.

Collaboration with Jeong Dong Lee and Hyung Seok Park



Commentaires


Featured Posts
Recent Posts
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

서울특별시 서대문구 연세로 50-1, 연세대학교 의과대학 신관 616호

#616 Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea  

+82-2-2228-2589

02-2228-2589 (inside Korea)

  • w-facebook
  • Twitter Clean
  • w-googleplus
  • W-Pinterest

© Since 2014 Translational Genome Informatics Laboratory,

Yonsei University College of Medicine.

Proudly created with Wix.com

bottom of page